BenignPhyllodesTumorMastodyniaMegestrolAcetatemTORInhibitorsEGFR(epidermalgrowth factorreceptor)AromataseInhibitorsDoxorubicinAdvocacySelf-examinationLumpectomyTriplePositiveBreastCancerPathologicResponseCMFChemotherapyPrecisionMedicineAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenIn-situCarcinomaFamilyHistoryChemotherapyCyclophosphamideKi-67RateER+LumpPARPInhibitorsGuaranteedRenewableInsuranceDoseDenseTherapyEvidencesuggests thatphysical activitymay reduce therisk of breastcancersBreastCancerNodePositiveCDK4/6InhibitorsStagingLiquidBiopsyRadiotherapyApoptosisMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltCytotoxicRaloxifeneHormoneReceptorStatusNodeNegativeInvasiveBreastCancerFlowCytometryAdjuvantTherapyAxillarySamplingHormoneReplacementTherapyLymphNodeStatusLCISEndometrialCancerAngiogenesisEstradiolMetastasisBOCASclerosingAdenosisRelapselatissimusflapKappaEpsilonMultifocalTumorsAdenocarcinomaCalcificationsCheckpointInhibitorPagetDiseaseCystProgestinLapatinibTripleNegativeBreastCancerMastalgiaBevacizumabMRIOophorectomyLymphoscintigraphyNeoadjuvantTherapyGenomicTestingAbsoluteRiskPalpation1 in 8womenOvarianSuppressionPhyllodesTumorECOGScoreEstrogenBreastTomosynthesisNeoplasmOligometastasesExcisionalBiopsyMastitisPalbociclibDiabeticMastopathyPI3KinaseInhibitorsRADWomen ages40+ shouldhave a clinicalbreast examat least yearlyWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.ER-FibroadenomaGermlineMutationCo-survivorIntraductalPapillomaHER-2Disease-FreeSurvivalRateImmunotherapyAntiemeticTyrosine-KinaseInhibitorFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.GeneticPredispositionMethotrexateGailModelBI-RADSAlopeciaChemopreventionBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55Down-StagingHerceptinMultimodalityTherapyCachexiaGeneMutationBrachytherapyDefinitiveSurgeryCytostaticMetastaticBreastCancerAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerSERMCAMCapecitabineTamoxifenAnastrozoleBilateralProphylacticMastectomyBRCAGeneMorpheaPaclitaxel5-FluorouracilMastectomyGeneticCounselingFISHACChemotherapyDocetaxelAntibodyTherapyTumorGradeAyurvedaEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearMolecularBreastImagingBiopsyDimplingBenignPhyllodesTumorMastodyniaMegestrolAcetatemTORInhibitorsEGFR(epidermalgrowth factorreceptor)AromataseInhibitorsDoxorubicinAdvocacySelf-examinationLumpectomyTriplePositiveBreastCancerPathologicResponseCMFChemotherapyPrecisionMedicineAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenIn-situCarcinomaFamilyHistoryChemotherapyCyclophosphamideKi-67RateER+LumpPARPInhibitorsGuaranteedRenewableInsuranceDoseDenseTherapyEvidencesuggests thatphysical activitymay reduce therisk of breastcancersBreastCancerNodePositiveCDK4/6InhibitorsStagingLiquidBiopsyRadiotherapyApoptosisMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltCytotoxicRaloxifeneHormoneReceptorStatusNodeNegativeInvasiveBreastCancerFlowCytometryAdjuvantTherapyAxillarySamplingHormoneReplacementTherapyLymphNodeStatusLCISEndometrialCancerAngiogenesisEstradiolMetastasisBOCASclerosingAdenosisRelapselatissimusflapKappaEpsilonMultifocalTumorsAdenocarcinomaCalcificationsCheckpointInhibitorPagetDiseaseCystProgestinLapatinibTripleNegativeBreastCancerMastalgiaBevacizumabMRIOophorectomyLymphoscintigraphyNeoadjuvantTherapyGenomicTestingAbsoluteRiskPalpation1 in 8womenOvarianSuppressionPhyllodesTumorECOGScoreEstrogenBreastTomosynthesisNeoplasmOligometastasesExcisionalBiopsyMastitisPalbociclibDiabeticMastopathyPI3KinaseInhibitorsRADWomen ages40+ shouldhave a clinicalbreast examat least yearlyWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.ER-FibroadenomaGermlineMutationCo-survivorIntraductalPapillomaHER-2Disease-FreeSurvivalRateImmunotherapyAntiemeticTyrosine-KinaseInhibitorFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.GeneticPredispositionMethotrexateGailModelBI-RADSAlopeciaChemopreventionBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55Down-StagingHerceptinMultimodalityTherapyCachexiaGeneMutationBrachytherapyDefinitiveSurgeryCytostaticMetastaticBreastCancerAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerSERMCAMCapecitabineTamoxifenAnastrozoleBilateralProphylacticMastectomyBRCAGeneMorpheaPaclitaxel5-FluorouracilMastectomyGeneticCounselingFISHACChemotherapyDocetaxelAntibodyTherapyTumorGradeAyurvedaEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearMolecularBreastImagingBiopsyDimpling

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
  1. Benign Phyllodes Tumor
  2. Mastodynia
  3. Megestrol Acetate
  4. mTOR Inhibitors
  5. EGFR (epidermal growth factor receptor)
  6. Aromatase Inhibitors
  7. Doxorubicin
  8. Advocacy
  9. Self-examination
  10. Lumpectomy
  11. Triple Positive Breast Cancer
  12. Pathologic Response
  13. CMF Chemotherapy
  14. Precision Medicine
  15. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  16. In-situ Carcinoma
  17. Family History
  18. Chemotherapy
  19. Cyclophosphamide
  20. Ki-67 Rate
  21. ER+
  22. Lump
  23. PARP Inhibitors
  24. Guaranteed Renewable Insurance
  25. Dose Dense Therapy
  26. Evidence suggests that physical activity may reduce the risk of breast cancers
  27. Breast Cancer
  28. Node Positive
  29. CDK4/6 Inhibitors
  30. Staging
  31. Liquid Biopsy
  32. Radiotherapy
  33. Apoptosis
  34. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  35. Cytotoxic
  36. Raloxifene
  37. Hormone Receptor Status
  38. Node Negative
  39. Invasive Breast Cancer
  40. Flow Cytometry
  41. Adjuvant Therapy
  42. Axillary Sampling
  43. Hormone Replacement Therapy
  44. Lymph Node Status
  45. LCIS
  46. Endometrial Cancer
  47. Angiogenesis
  48. Estradiol
  49. Metastasis
  50. BOCA
  51. Sclerosing Adenosis
  52. Relapse
  53. latissimus flap
  54. Kappa Epsilon
  55. Multifocal Tumors
  56. Adenocarcinoma
  57. Calcifications
  58. Checkpoint Inhibitor
  59. Paget Disease
  60. Cyst
  61. Progestin
  62. Lapatinib
  63. Triple Negative Breast Cancer
  64. Mastalgia
  65. Bevacizumab
  66. MRI
  67. Oophorectomy
  68. Lymphoscintigraphy
  69. Neoadjuvant Therapy
  70. Genomic Testing
  71. Absolute Risk
  72. Palpation
  73. 1 in 8 women
  74. Ovarian Suppression
  75. Phyllodes Tumor
  76. ECOG Score
  77. Estrogen
  78. Breast Tomosynthesis
  79. Neoplasm
  80. Oligometastases
  81. Excisional Biopsy
  82. Mastitis
  83. Palbociclib
  84. Diabetic Mastopathy
  85. PI3 Kinase Inhibitors
  86. RAD
  87. Women ages 40+ should have a clinical breast exam at least yearly
  88. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  89. ER-
  90. Fibroadenoma
  91. Germline Mutation
  92. Co-survivor
  93. Intraductal Papilloma
  94. HER-2
  95. Disease-Free Survival Rate
  96. Immunotherapy
  97. Antiemetic
  98. Tyrosine-Kinase Inhibitor
  99. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  100. Genetic Predisposition
  101. Methotrexate
  102. Gail Model
  103. BI-RADS
  104. Alopecia
  105. Chemoprevention
  106. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  107. Down-Staging
  108. Herceptin
  109. Multimodality Therapy
  110. Cachexia
  111. Gene Mutation
  112. Brachytherapy
  113. Definitive Surgery
  114. Cytostatic
  115. Metastatic Breast Cancer
  116. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  117. SERM
  118. CAM
  119. Capecitabine
  120. Tamoxifen
  121. Anastrozole
  122. Bilateral Prophylactic Mastectomy
  123. BRCA Gene
  124. Morphea
  125. Paclitaxel
  126. 5-Fluorouracil
  127. Mastectomy
  128. Genetic Counseling
  129. FISH
  130. AC Chemotherapy
  131. Docetaxel
  132. Antibody Therapy
  133. Tumor Grade
  134. Ayurveda
  135. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  136. Molecular Breast Imaging
  137. Biopsy
  138. Dimpling